IDEXX Laboratories, Inc. (IDXX) Q4 2016 Earnings Results

IDEXX Laboratories Beats on EPS, Stock Up 13.25%

IDEXX Laboratories reported a better-than-expected EPS for the quarter, which contributed to a significant stock increase of 13.25%. Investors reacted positively to the earnings surprise, although no revenue figures or guidance updates were provided. The strong EPS performance indicates potential confidence in the company's profitability.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.58	N/A	+14.85%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

IDEXX Laboratories Beats on EPS, Stock Up 13.25%

Key numbers

Management commentary

IDEXX Laboratories, Inc.

More earnings this week

IDEXX Laboratories Beats on EPS, Stock Up 13.25%

Key numbers

Management commentary